SILO PHARMA, INC. Accounts Payable
SILO PHARMA, INC. (SILO) had Accounts Payable of $143.61 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2023-11-13
- 2023-09-30: Accounts Payable, Current $143.61K.
- 2012-09-30: Accounts Payable, Current $14.28K.
- 2012-06-30: Accounts Payable, Current $6.27K.
- 2012-03-31: Accounts Payable, Current $3.50K.
| Period end | Accounts Payable, Current |
|---|---|
| 2023-09-30 | $143.61K 10-Q · filed 2023-11-13 |
| 2012-09-30 | $14.28K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $6.27K 10-Q · filed 2012-08-01 |
| 2012-03-31 | $3.50K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $3.50K 10-Q · filed 2012-11-13 |
| 2011-06-30 | $3.50K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $0.00 10-K · filed 2012-01-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |